KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revvity (RVTY) Research & Development (2016 - 2025)

Revvity's Research & Development history spans 17 years, with the latest figure at $58.2 million for Q4 2025.

  • For Q4 2025, Research & Development rose 18.22% year-over-year to $58.2 million; the TTM value through Dec 2025 reached $215.8 million, up 9.65%, while the annual FY2025 figure was $215.8 million, 9.65% up from the prior year.
  • Research & Development reached $58.2 million in Q4 2025 per RVTY's latest filing, up from $50.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $81.9 million in Q1 2023 to a low of -$2.1 million in Q1 2021.
  • Average Research & Development over 5 years is $52.6 million, with a median of $53.4 million recorded in 2022.
  • The largest YoY upside for Research & Development was 32.92% in 2021 against a maximum downside of 104.46% in 2021.
  • A 5-year view of Research & Development shows it stood at $49.4 million in 2021, then increased by 8.3% to $53.5 million in 2022, then fell by 7.33% to $49.6 million in 2023, then decreased by 0.78% to $49.2 million in 2024, then rose by 18.22% to $58.2 million in 2025.
  • Per Business Quant, the three most recent readings for RVTY's Research & Development are $58.2 million (Q4 2025), $50.8 million (Q3 2025), and $53.3 million (Q2 2025).